Article
Pacritinib abrogates the lupus phenotype in ABIN1[D485N] mice.
Lupus science & medicine - 1 Feb 2023
Petrova Tsvetana, Figueras-Vadillo Clara, Nanda Sambit K, Scudamore Cheryl, Cohen Philip
Abstract excerpt
OBJECTIVE: The aim of the study was to investigate whether the IRAK1/JAK2/Flt3 inhibitor pacritinib prevents disease development in the lupus-prone ABIN1[D485N] knock-in mouse. METHODS: ABIN1[D485N] knock-in mice aged 8 weeks were fed for 10 weeks on a diet containing pacritinib. Body weight was monitored, and serum collected at the end to measure pacritinib, autoantibody and immunoglobulin levels. Splenic immune...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
